Article thumbnail

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

By M. Andreeff, K. R. Kelly, K. Yee, S. Assouline, R. Strair, L. Popplewell, D. Bowen, G. Martinelli, M. W. Drummond, P. Vyas, M. Kirschbaum, S. P. Iyer, V. Ruvolo, G. M. N. Gonzalez, X. Huang, G. Chen, B. Graves, S. Blotner, P. Bridge, L. Jukofsky, S. Middleton, M. Reckner, R. Rueger, J. Zhi, G. Nichols and K. Kojima
Publisher: American Association for Cancer Research (AACR)
Year: 2015
DOI identifier: 10.1158/1078-0432.ccr-15-0481
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://clincancerres.aacrjourn... (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.